Literature DB >> 30222362

Evaluating the Utility of Canine Mdr1 Knockout Madin-Darby Canine Kidney I Cells in Permeability Screening and Efflux Substrate Determination.

Eugene C Chen1, Fabio Broccatelli1, Emile Plise1, Buyun Chen1, Liling Liu1, Jonathan Cheong1, Shu Zhang1, Jamie Jorski1, Katherine Gaffney1, Kayla K Umemoto1, Laurent Salphati1.   

Abstract

Permeability assays are commonly conducted with Madin-Darby canine kidney (MDCK) cells to predict the intestinal absorption of small-molecule drug candidates. In addition, MDCK cells transfected to overexpress efflux transporters are often used to identify substrates. However, MDCK cells exhibit endogenous efflux activity for a significant proportion of experimental compounds, potentially leading to the underestimation of permeability and confounded findings in transport studies. The goal of this study was to evaluate canine Mdr1 knockout MDCK (gMDCKI) cells in permeability screening and human MDR1 substrate determination in a drug discovery setting. The gMDCKI cells were established by CRISPR-Cas9-mediated knockout of the canine Mdr1 gene in MDCKI wildtype (wt) cells. A comparison of efflux ratios (ER) between MDCKI wt and gMDCKI showed that out of 135 compounds tested, 38% showed efflux activity in MDCKI wt, while no significant efflux was observed in gMDCKI cells. Apparent permeability (Papp) from apical-to-basolateral (A-to-B) and basolateral-to-apical were near unity in gMDCKI cells, which approximated passive permeability, and 17% of compounds demonstrated increases in their Papp A-to-B values. Overexpression of human MDR1 in gMDCKI (gMDCKI-MDR1) cells enabled substrate determination without the contribution of endogenous efflux, and the assay was able to deconvolute ambiguous results from MDCKI-MDR1 and identify species differences in substrate specificity. An analysis of 395 and 474 compounds in gMDCKI and gMDCKI-MDR1, respectively, suggested physicochemical properties that were associated with low permeability correlated with MDR1 recognition. Poorly permeable compounds and MDR1 substrates were more likely to be large, flexible, and more capable of forming external hydrogen bonds. On the basis of our evaluation, we concluded that gMDCKI is a better cell line for permeability screening and efflux substrate determination than the MDCK wt cell line.

Entities:  

Keywords:  MDCK cells; P-glycoprotein; multidrug resistance transporters; permeability

Mesh:

Substances:

Year:  2018        PMID: 30222362     DOI: 10.1021/acs.molpharmaceut.8b00688

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  4 in total

Review 1.  Application of CRISPR-Cas9 System to Study Biological Barriers to Drug Delivery.

Authors:  Ji He; Riya Biswas; Piyush Bugde; Jiawei Li; Dong-Xu Liu; Yan Li
Journal:  Pharmaceutics       Date:  2022-04-20       Impact factor: 6.525

Review 2.  Recent advances in the translation of drug metabolism and pharmacokinetics science for drug discovery and development.

Authors:  Yurong Lai; Xiaoyan Chu; Li Di; Wei Gao; Yingying Guo; Xingrong Liu; Chuang Lu; Jialin Mao; Hong Shen; Huaping Tang; Cindy Q Xia; Lei Zhang; Xinxin Ding
Journal:  Acta Pharm Sin B       Date:  2022-03-17       Impact factor: 14.903

3.  Turning the Other Cheek: Influence of the cis-Tetrafluorocyclohexyl Motif on Physicochemical and Metabolic Properties.

Authors:  Yong Wang; Wendy Lee; Yi-Chen Chen; Yuhui Zhou; Emile Plise; Madyson Migliozzi; James J Crawford
Journal:  ACS Med Chem Lett       Date:  2022-08-14       Impact factor: 4.632

4.  Understanding the Effect of Hydroxypropyl-β-Cyclodextrin on Fenebrutinib Absorption in an Itraconazole-Fenebrutinib Drug-Drug Interaction Study.

Authors:  Matthew R Durk; Nicholas S Jones; Jia Liu; Karthik Nagapudi; Chen Mao; Emile G Plise; Susan Wong; Jacob Z Chen; Yuan Chen; Leslie W Chinn; Po-Chang Chiang
Journal:  Clin Pharmacol Ther       Date:  2020-07-18       Impact factor: 6.875

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.